| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.09.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION... ► Artikel lesen | |
| 30.08.24 | Advantagewon Oil Corp (2): Advantagewon delisted from CSE | ||
| 30.08.24 | CSE Bulletin: Delist - Advantagewon Oil Corp. (AOC) | le 30 août/August 2024
The common shares of Advantagewon Oil Corp. will be delisted from the CSE at market close today, August 30, 2024.
Advantagewon Oil Corp. is currently suspended. See Bulletin... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.12.24 | Entersoft-Softone Merger: A leader in Business Software | ||
| 29.10.24 | ENTERSOFT: New acquisition and the battle with Viva | ||
| 11.10.24 | Viva's injunctions against SoftOne-Entersoft rejected | ||
| 02.09.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION... ► Artikel lesen | |
| 02.09.24 | SECURITIES MARKET INFORMATION BULLETIN 02/09/2024: KRE.KA S.A., LIVANIS PUBLICATIONS S.A., VARVARESSOS S.A., ENTERSOFT S.A. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.02. | Matinas BioPharma announces agreement for the acquisition of preferred stock | ||
| 13.02. | Matinas BioPharma Holdings, Inc.: Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors | ||
| 07.02. | Matinas BioPharma Holdings, Inc.: Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair | ||
| 07.02. | Matinas BioPharma Holdings, Inc. - 8-K, Current Report | ||
| 24.01. | Matinas BioPharma Holdings, Inc. - 8-K, Current Report |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.11.24 | Mattioli Woods: Profit slashed at wealth manager as it quit London | ||
| 04.09.24 | AIM - Cancellation - MATTIOLI WOODS PLC | ||
| 03.09.24 | Mattioli Woods PLC - Scheme Effective | ||
| 03.09.24 | AIM - Suspension - Mattioli Woods plc | ||
| 02.09.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.02. | Oruka Therapeutics, Inc. - 8-K, Current Report | ||
| 19.12.24 | Oruka Therapeutics, Inc.: Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody | Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial efficacy... ► Artikel lesen | |
| 19.12.24 | Oruka Therapeutics, Inc. - 8-K, Current Report | ||
| 18.12.24 | Oruka Therapeutics, Inc.: Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) | MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. ("Oruka") (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment... ► Artikel lesen | |
| 10.12.24 | Frazier Life Sciences Management L.P. Purchases New Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.02. | OXURION: Oxurion strengthens its Board of Directors with the arrival of Nelly Souleymane | LEUVEN, BELGIUM - February 14, 2024 - 7:00PM, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces a change in its Board of Directors with the departure... ► Artikel lesen | |
| 20.01. | OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | Leuven, BELGIUM - January 20, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen | |
| 14.01. | OXURION: Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLC | Leuven, BELGIUM - January 14, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen | |
| 13.01. | OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | Leuven, BELGIUM - January 13, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen | |
| 13.01. | OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas | Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ADVANTAGEWON OIL CORP | - | - |
| ENTERSOFT SA | 7,920 | 0,00 % |
| MATINAS BIOPHARMA HOLDINGS INC | 0,645 | +10,94 % |
| MATTIOLI WOODS PLC | 9,250 | 0,00 % |
| ORUKA THERAPEUTICS INC | 10,700 | +1,90 % |
| OXURION NV | 0,194 | 0,00 % |
